Extending human IgG half-life using structure-guided design

Engineering of antibodies for improved pharmacokinetics through enhanced binding to the neonatal Fc receptor (FcRn) has been demonstrated in transgenic mice, non-human primates and humans. Traditionally, such approaches have largely relied on random mutagenesis and display formats, which fail to add...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:MAbs
Asıl Yazarlar: Booth, Brian J., Ramakrishnan, Boopathy, Narayan, Kristin, Wollacott, Andrew M., Babcock, Gregory J., Shriver, Zachary, Viswanathan, Karthik
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2018
Konular:
Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6204840/
https://ncbi.nlm.nih.gov/pubmed/29947573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2018.1490119
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller